Medtronic (NYSE: MDT) announced that it appointed Dr. Gerald "Jeb" Denny as chief medical officer for Acute Care & Monitoring ...
Hugo is about to joust da Vinci. It’s not a battle between Renaissance geniuses. Instead, a commercial fight is brewing ...
Jeb Denny started at Medtronic on Tuesday in the company’s acute care and monitoring business, which makes pulse oximeters, ...
The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population DUBLIN, Sept. 20, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader ...
Medtronic has its heart set on ensuring that its insertable cardiac monitors are as accurate as possible, and a new pair of artificial intelligence algorithms might be just the ticket. The AccuRhythm ...
ISC23: Late-breaking results from STROKE AF study reinforce importance of long-term continuous cardiac monitoring in ischemic stroke patients DUBLIN and DALLAS, Feb. 8, 2023 /PRNewswire/ -- Medtronic ...
Medtronic issues recall diabetes software affecting CareLink version 4.2B due to incorrect glucose data display, prompting clinician review.
It started with black bears. It was 1999, and University of Minnesota researcher Paul Iaizzo connected with Tim Laske, now vice president of research in Medtronic's cardiac ablation products business.
Medtronic's Reveal XT subcutaneous cardiac monitor is now commercially available in the U.S. The company introduced Reveal XT in Europe in July of 2007. The device helps physicians diagnose heart ...
The partnership is the first time Medtronic has integrated its insulin pumps with a sensor developed outside of the company.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results